Cambridge Trust Co. Sells 132 Shares of FMC Co. (NYSE:FMC)

Cambridge Trust Co. lowered its stake in FMC Co. (NYSE:FMC – Get Rating) by 5.2% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,399 shares of the basic materials company’s stock after selling 132 shares during the quarter. Cambridge Trust Co.’s holdings in FMC were worth $299,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of FMC. Vanguard Group Inc. increased its stake in FMC by 0.7% in the third quarter. Vanguard Group Inc. now owns 14,253,322 shares of the basic materials company’s stock valued at $1,506,576,000 after purchasing an additional 99,473 shares in the last quarter. BlackRock Inc. increased its position in FMC by 1.8% in the 3rd quarter. BlackRock Inc. now owns 11,561,614 shares of the basic materials company’s stock valued at $1,222,062,000 after buying an additional 209,813 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in FMC by 14.3% in the 3rd quarter. Price T Rowe Associates Inc. MD now owns 3,085,382 shares of the basic materials company’s stock valued at $326,126,000 after buying an additional 386,465 shares in the last quarter. Northern Trust Corp raised its stake in FMC by 3.0% during the 2nd quarter. Northern Trust Corp now owns 2,124,398 shares of the basic materials company’s stock worth $227,332,000 after buying an additional 61,796 shares during the period. Finally, Manning & Napier Group LLC boosted its holdings in FMC by 30.0% in the third quarter. Manning & Napier Group LLC now owns 1,727,229 shares of the basic materials company’s stock worth $182,566,000 after acquiring an additional 398,785 shares in the last quarter. Institutional investors and hedge funds own 88.28% of the company’s stock.

Analyst Upgrades and Downgrades

FMC has been the topic of a number of research reports. Mizuho reaffirmed a “buy” rating and set a $146.00 target price on shares of FMC in a research report on Wednesday, February 8th. Morgan Stanley upgraded shares of FMC from an “equal weight” rating to an “overweight” rating and upped their price objective for the stock from $125.00 to $145.00 in a report on Tuesday, January 10th. StockNews.com began coverage on shares of FMC in a report on Thursday. They set a “buy” rating for the company. KeyCorp boosted their target price on shares of FMC from $140.00 to $144.00 and gave the stock an “overweight” rating in a research report on Thursday, February 9th. Finally, Redburn Partners raised shares of FMC from a “neutral” rating to a “buy” rating and set a $155.00 price target on the stock in a research report on Friday. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, FMC presently has an average rating of “Moderate Buy” and a consensus target price of $144.08.

Insiders Place Their Bets

In other news, EVP Ronaldo Pereira sold 1,955 shares of the firm’s stock in a transaction that occurred on Wednesday, March 1st. The shares were sold at an average price of $129.29, for a total transaction of $252,761.95. Following the completion of the sale, the executive vice president now owns 19,478 shares in the company, valued at approximately $2,518,310.62. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In other FMC news, EVP Ronaldo Pereira sold 1,955 shares of the stock in a transaction on Wednesday, March 1st. The stock was sold at an average price of $129.29, for a total transaction of $252,761.95. Following the completion of the transaction, the executive vice president now directly owns 19,478 shares of the company’s stock, valued at $2,518,310.62. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO Andrew D. Sandifer sold 5,000 shares of the firm’s stock in a transaction on Thursday, March 2nd. The stock was sold at an average price of $127.77, for a total value of $638,850.00. Following the completion of the sale, the chief financial officer now directly owns 39,061 shares of the company’s stock, valued at $4,990,823.97. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 11,376 shares of company stock valued at $1,465,016. Company insiders own 0.57% of the company’s stock.

FMC Price Performance

Shares of NYSE FMC opened at $116.07 on Friday. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $14.52 billion, a PE ratio of 19.94, a PEG ratio of 1.46 and a beta of 0.84. The stock’s 50 day moving average price is $127.42 and its 200-day moving average price is $121.98. FMC Co. has a twelve month low of $98.24 and a twelve month high of $140.99.

FMC (NYSE:FMC – Get Rating) last posted its quarterly earnings data on Wednesday, February 8th. The basic materials company reported $2.37 earnings per share for the quarter, topping the consensus estimate of $2.32 by $0.05. The business had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.53 billion. FMC had a return on equity of 29.29% and a net margin of 12.69%. The business’s revenue was up 14.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.16 earnings per share. On average, equities analysts anticipate that FMC Co. will post 7.92 EPS for the current year.

FMC Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 20th. Investors of record on Friday, March 31st will be issued a dividend of $0.58 per share. The ex-dividend date is Thursday, March 30th. This represents a $2.32 dividend on an annualized basis and a yield of 2.00%. FMC’s dividend payout ratio (DPR) is presently 39.86%.

FMC Company Profile

(Get Rating)

FMC Corp. is an agricultural sciences company, which engages in the provision of solutions to growers and development of pipeline in crop protection, plant health, precision agriculture, and professional pest, and turf management. It offers insect control products under the Rynaxypyr and Cyazypyr brands, herbicides under the Authority, Boral, Centium, Command, and Gamit brands, insecticides under the Talstar and Hero brands, flutriafol-based fungicides, and bionematicides under the Quartzo and Presence brands.